FDA
-
-
-
-
-
-
-
Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.
-
-
-
-
-
-
-
Strongbridge Biopharma plc Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
-
-
-
-
-
-
-
Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases
-
-
-
-
-
-
-
Strongbridge Biopharma plc to Host First Quarter 2021 Financial Results Conference Call on May 12, 2021
-
-
-
-
-
-
-
Strongbridge Biopharma plc to Present at Oppenheimer’s 31st Annual Healthcare Conference
-
-
-
-
-
-
-
Strongbridge Biopharma plc Announces New Employment Inducement Awards
-
-
-
-
-
-
-
Pre-Open Movers 09/17: (SRNE) (MLHR) (RIGL) Higher; (SBBP) (NCNA) (SNOW) Lower (more...)
-
322,242 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

